ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
07.08.2025 - 18:04:22 | prnewswire.co.uk
en | CA7609751028 | ARTBIO | boerse | 67984792 |
